# Oxytocin Dosing at Planned Cesarean Section and Anemia

> **NCT03361124** · PHASE4 · WITHDRAWN · sponsor: **Milton S. Hershey Medical Center**

## Conditions studied

- Blood Loss Anemia
- Uterine Atony With Hemorrhage

## Interventions

- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT03361124
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-03-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator no longer interested in proceeding with study
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03361124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03361124, "Oxytocin Dosing at Planned Cesarean Section and Anemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03361124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*